Should pharmaceutical companies publish all their data?

I'm currently involved in a survey, designed to find out more about attitudes to pharmaceutical companies publishing all of their clinical data.

The objective of this short survey is to gain feedback as to how much trial data pharmaceutical companies should make public. The types of questions asked within the survey include, "Should pharma make all their data public, and if so, how where should they publish their data", and "What are the limitations on publishing all data?". The survey is aimed at professionals involved in the development, publishing or planning of medical publications.

If you are involved in publishing medical research, I'd be really grateful if you could spare a few minutes to take part in the survey, which you can do by clicking here.

And please feel free to tell any of your colleagues about it too.